BLACKLINE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BLACKLINE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $50.23M | Mar 8, 2018 |
| FY2017 | Sep 30, 2017 | $45.87M | Mar 8, 2018 |
| FY2017 | Jun 30, 2017 | $42.29M | Mar 8, 2018 |
| FY2017 | Mar 31, 2017 | $38.63M | Mar 8, 2018 |
| FY2017 | Dec 31, 2016 | $35.34M | Mar 8, 2018 |
| FY2017 | Sep 30, 2016 | $32.20M | Mar 8, 2018 |
| FY2017 | Jun 30, 2016 | $29.03M | Mar 8, 2018 |
| FY2017 | Mar 31, 2016 | $26.56M | Mar 8, 2018 |
| FY2016 | Dec 31, 2015 | $24.47M | Mar 10, 2017 |
| FY2016 | Sep 30, 2015 | $21.66M | Mar 10, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $700.43M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $653.34M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $590.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $522.94M | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | $115.33M | Mar 24, 2022 |
| FY2021 | Sep 30, 2021 | $109.40M | Mar 24, 2022 |
| FY2021 | Jun 30, 2021 | $102.12M | Mar 24, 2022 |
| FY2021 | Mar 31, 2021 | $98.86M | Mar 24, 2022 |
| FY2021 | Dec 31, 2020 | $95.71M | Mar 24, 2022 |
| FY2021 | Sep 30, 2020 | $90.16M | Mar 24, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $527.04M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $491.37M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $443.20M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $393.55M | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | $87.35M | Mar 24, 2022 |
| FY2021 | Sep 30, 2021 | $84.97M | Mar 24, 2022 |
| FY2021 | Jun 30, 2021 | $78.55M | Mar 24, 2022 |
| FY2021 | Mar 31, 2021 | $76.97M | Mar 24, 2022 |
| FY2021 | Dec 31, 2020 | $76.53M | Mar 24, 2022 |
| FY2021 | Sep 30, 2020 | $73.18M | Mar 24, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.52M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $161.17M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $52.83M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($29.39M) | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | ($37.01M) | Mar 24, 2022 |
| FY2021 | Sep 30, 2021 | ($13.74M) | Mar 24, 2022 |
| FY2021 | Jun 30, 2021 | ($25.45M) | Mar 24, 2022 |
| FY2021 | Mar 31, 2021 | ($38.96M) | Mar 24, 2022 |
| FY2021 | Dec 31, 2020 | ($16.99M) | Mar 24, 2022 |
| FY2021 | Sep 30, 2020 | ($8.75M) | Mar 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.55M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $18.54M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $14.35M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($56.20M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | ($38.61M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | ($19.89M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($27.90M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | ($29.84M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | ($30.41M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($23.18M) | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.20M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $100.97M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $103.21M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $108.89M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $77.32M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $56.46M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $43.01M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $30.75M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $23.87M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $21.13M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $169.57M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $190.84M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $126.61M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $56.01M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $80.09M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $54.74M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $29.72M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $16.14M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $6.42M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($4.81M) | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.07M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.13M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.95M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $10.97M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $8.73M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $6.51M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.63M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $6.28M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.72M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.83B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.10B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.94B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.82B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.11B | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $493.48M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $460.81M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $420.44M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.81B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.81B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.46B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $678.91M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $611.03M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $169.83M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $143.51M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $129.03M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $332.33M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $446.67M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $260.88M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $111.87M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $325.04M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $422.07M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $398.61M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $319.27M | Mar 24, 2022 |
| FY2020 | Dec 31, 2017 | $315.91M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $308.04M | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $465.80M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $448.97M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $448.97M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $443.86M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $289.71M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $289.71M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $185.14M | Mar 24, 2022 |
| FY2019 | Dec 31, 2018 | $185.14M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $185.14M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $185.14M | Mar 8, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($24.82M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($48.99M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($214.80M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | ($272.97M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($301.74M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($201.65M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($163.60M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($132.90M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($102.79M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($87.33M) | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $390.03M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $885.92M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $271.12M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $200.97M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $539.74M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $367.41M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $120.23M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $46.18M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $31.10M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $22.12M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Mar 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Mar 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59.88M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 62.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 61.52M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 60.02M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 58.98M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 57.68M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 55.93M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 54.68M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 52.98M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 51.28M | Mar 8, 2018 |